International heath technology assessment collaboration expands

24 August 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has ...

Read more →

Lenvatinib mesylate in combination with pembrolizumab for the first-line treatment of patients with advanced renal cell carcinoma

30 November 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use of ...

Read more →

NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice

6 February 2019 - NICE and the Canadian Agency for Drugs and Technology in Health have launched a new collaboration to ...

Read more →